Aristada (Aripiprazole Lauroxil Extended-release Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 13, 2017 Category: Drugs & Pharmacology Source Type: news
The drug that makes you binge on sex, gambling and food
The antipsychotic drug Abilify, used to treat schizophrenia and depression, is at the center of hundreds of lawsuits over claims that side effects included gambling and binge shopping (Source: the Mail online | Health)
Source: the Mail online | Health - February 17, 2017 Category: Consumer Health News Source Type: news
Once-Monthly Aripiprazole Effective in Bipolar Disorder Once-Monthly Aripiprazole Effective in Bipolar Disorder
The once-monthly injection, currently available for schizophrenia, is seen as a potentially important tool to prevent nonadherence.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 14, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Aripiprazole Oral Solution (Aripiprazole Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 13, 2017 Category: Drugs & Pharmacology Source Type: news
Aripiprazole Tablets (Aripiprazole Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 13, 2017 Category: Drugs & Pharmacology Source Type: news
Florida, other states settle with Bristol-Myers Squibb over antipsychotic drug
Florida will get a piece of a $19.5 million settlement with Bristol-Myers Squibb Co. in a case alleging the drug company improperly marketed Abilify.
According to a multi-state complaint filed by Florida Attorney General Pam Bondi and attorneys general in 42 other states and the District of Columbia, Bristol-Myers Squibb (NYSE: BMY) promoted the antipsychotic drug for treating elderly patients and children for uses that were not approved by the U.S. Food& Drug Administration.
See the final judgment… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 12, 2016 Category: Biotechnology Authors: Margie Manning Source Type: news
Morning Break: Heroin Deadlier than Guns; Abilify Fines; Interstate Insurance Flops
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - December 9, 2016 Category: Respiratory Medicine Source Type: news
Bristol-Myers Squibb to pay $19.5 million over Abilify marketing
Bristol-Myers Squibb on Thursday struck a $19.5 million settlement to resolve claims by 43 states, that it marketed an antipsychotic drug to elderly patients and children for unapproved conditions.
Massachusetts Attorney General Maura Healey said in a statement that more than $400,000 of the funds would go to the state.
BMS (NYSE: BMY), which is headquartered in New York City and has a manufacturing facility in Devens, Mass., was accused of engaging in unfair and deceptive trade practices t hrough… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 9, 2016 Category: Biotechnology Authors: Max Stendahl Source Type: news
Effect of aripiprazole augmentation for the depressive symptoms changes with progression of Lewy body disease - Iwamoto K, Fujishiro H, Ozaki N.
This report shows that aripiprazol... (Source: SafetyLit)
Source: SafetyLit - November 25, 2016 Category: Global & Universal Tags: Age: Elder Adults Source Type: news
UCLA awarded grant to study depression in older adults
More than half of older adults who are treated for depression find that eventually their treatments are no longer effective. When depression persists, these people are at greater risk of accelerated aging, declining mental health and even suicide.To help address this, UCLA and four other institutions have been awarded a $13.9 million grant to evaluate treatment strategies for older adults with depression who have not responded to medications. UCLA psychiatry professor Dr. Helen Lavretsky will serve as principal investigator on this new study.“No more than 30 to 40 percent of people respond to first-line treatments,” sa...
Source: UCLA Newsroom: Health Sciences - September 30, 2016 Category: Universities & Medical Training Source Type: news
Abilify Maintena (Aripiprazole Extended-Release Injectable Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 7, 2016 Category: Drugs & Pharmacology Source Type: news
Aripiprazole in the treatment of obsessive compulsive disorder and aggressive behaviors in a child with Prader Willi syndrome: a case report - Akca OF, Yilmaz S.
[Abstract unavailable]
Language: en... (Source: SafetyLit)
Source: SafetyLit - August 19, 2016 Category: Global & Universal Tags: Age: Infants and Children Source Type: news
A new method cuts the cost of drug-building chemicals
EPFL (École polytechnique fédérale de Lausanne) scientists design a new method to cheaply produce some of the most important chemical compounds in the pharmaceutical industry - the amines. The amines are one of the most important classes of chemical compounds today. Amines that contain a ring-like structure - called an "aryl" group - are used widely in pharmaceuticals, such as the top-selling drugs Abilify, Crestor, Gleevec, and Lidoderm. (Source: World Pharma News)
Source: World Pharma News - August 12, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Aripiprazole reduces severity of tics in children with Tourette's disorder
(Mary Ann Liebert, Inc./Genetic Engineering News) A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group. The drug was safe, with drowsiness, nausea, and headache being the most common adverse effects, according to the study published in Journal of Child and Adolescent Psychopharmacology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2016 Category: Global & Universal Source Type: news
Aripiprazole for autism spectrum disorders (ASD)
Autism spectrum disorders (ASD) include autistic disorder, Asperger's disorder and pervasive developmental disorder - not otherwise specified (PDD-NOS). Antipsychotics have been used as a medication intervention for irritability related to ASD. Aripiprazole, a third-generation, atypical antipsychotic, is a relatively new drug that has a unique mechanism of action different from that of other antipsychotics. This review updates a previous Cochrane review on the safety and efficacy of aripiprazole for individuals with ASD, published in 2011 (Ching 2011).
To assess the safety and efficacy of aripiprazole as medication treatm...
Source: Current Awareness Service for Health (CASH) - July 12, 2016 Category: Consumer Health News Source Type: news
